DENTSPLY SIRONA Inc. (NASDAQ:XRAY) is garnering significant attention, as DekaBank Deutsche Girozentrale increased its stake in the medical instruments supplier by 25% during the 4th quarter. This move has brought about a sizable shift in the company’s holdings, which now account for roughly 0.05% of DENTSPLY SIRONA, with a net worth of $3.6 million.
DENTSPLY SIRONA recently reported better-than-expected earnings results at $0.46 EPS for the last quarter of 2016, though the revenue for this period was down to $983 million from an expected $939.11 million due to a drop of 10.9%. A positive return on equity was achieved at 8.71%, but margins were negatively impacted at -24.35%.
Analysts have been closely following DENTSPLY SIRONA and many have recently given their recommendations after analyzing current developments; upgrades in ratings were observed by William Blair who raised their rating from “underperform” to a “market perform” on January 11th followed by Piper Sandler lifting their price objective on DENTSPLY SIRONA to $35.00 and giving the stock a “neutral” rating on February 6th.
The Goldman Sachs Group also revised their target pricing from $34.00 to $39.00 whilst increasing their overall rating to neutral on March 1st along with upgrades from TheStreet, who rated DENTSPLY SIRONA from a “d+” to a “c” just two days prior.
Considering all these recent findings and results from top industry analysts, it can be confidently stated that DENTSPLY SIRONA has been performing positively in terms of growth potential which leads industry experts to believe that future earnings per share will prove successful for investors seeking long-term gains from this dynamic commercial entity.
Currently, the stock boasts an average rating of “Hold” with an average price target of $38.13, making it a sound choice for those interested in investing in a growing medical instruments company.
Changes in Holdings of Hedge Funds and Institutional Investors Impact DENTSPLY SIRONA’s Stock
The medical instruments supplier, DENTSPLY SIRONA, has seen modifications in holdings by hedge funds and other institutional investors. Macquarie Group Ltd increased its stake in the company by 3.2% during the second quarter, owning 8,879 shares of the stock worth $318,000 after purchasing an additional 274 shares in this period. Sumitomo Mitsui DS Asset Management Company Ltd bought an additional 279 shares, increasing their stake by 2% during the fourth quarter, whilst Signaturefd LLC raised its holdings by 20.8% during the same period. Kentucky Retirement Systems Insurance Trust Fund also saw a growth in holdings of 4.9% last quarter. Institutional investors now own a total of 98.52% of the company’s stock.
DENTSPLY SIRONA’s stock opened at $40.59 on Thursday with a twelve month low of $26.48 and a high of $43.68 within that period. The company boasts a market capitalisation of $8.74 billion and has reported quick ratio figures of 1.08 and current ratio figures of 1.62 alongside debt-to-equity ratios at 0.48.
Analysts have reviewed XRAY shares recently, providing an average rating among seven analysts as “Hold”, according to data from Bloomberg.com . William Blair upgraded shares from underperform to market perform on Wednesday January11th while Barrington Research upped its price target from $40 to $43 less than two months ago.
As is typical for public companies listed on exchanges across America, DENTSPLY SIRONA announced its quarterly dividend payment on Friday April14th with stockholders who owned on record as of close-of-business Friday March31st receiving a dividend dividend payout amounting to $0.125 per share or equivalent.
A report confirms that Cord Friedrich Staehler, Senior Vice President (SVP) at DENTSPLY SIRONA, sold 4,000 shares of company stock recently priced at an average of $39.33 per share for a total value of $157,320. Subsequently, the SVP currently holds 97,693 shares of the company’s stock valued at around $3,842,265.69. Insider ownership is a crucial factor in making investment decisions involving publicly-held companies such as DENTSPLY SIRONA.
In conclusion, changes in holdings by hedge funds and other institutional investors are common occurrences within exchange listed companies across America and remain essential components to monitor trends in business growth and can impact on future valuations positively or negatively.
